News at iBET

Introducing innate immunity to 3D tumour models


iBET and ITQB NOVA researchers developed a new 3D cell culture model to study the impact of the immune microenvironment of solid tumours in tumour progression and therapeutic response. The work was published in the journal Biomaterials

K4DD research published in Nature Communications


The work from K4DD partners iBET, Merck KGaA, Heidelberg Institute for Theoretical Studies and ITQB NOVA has resulted in a publication in the high-impact journal Nature Communications. 

Institutional Movie

AgroTech Campus


From curiosity-driven research to drug discovery, it has been a pleasure to work with the colleagues at iBET. 

Clive Wood

Corporate SVP and global head of Discovery Research, Boehringer Ingelheim

The ACTU has outstanding working conditions as any top research laboratory, which in my view is the natural result of the team efforts and positive synergies...

Tiago Vicente

International Product Manager, Octapharma, Switzerland

Facts & Figures